Recurrent/Metastatic Carcinosarcoma
1 clinical trials · Condition
◉ Watch Recurrent/Metastatic Carcinosarcoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab for Recurrent/Metastatic Carcinosarcoma (NCT05224999) | Yonsei University | 2019-11-13 |
Track Recurrent/Metastatic Carcinosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.